Status:
UNKNOWN
Digital Delivery of Patient Education: A Case Study of Symptom Self-Management During Cancer Treatment
Lead Sponsor:
Tel Aviv University
Collaborating Sponsors:
Weizmann Institute of Science
Conditions:
Digital Education Interventions
Knowledge Types (Mechanistic Versus Procedural)
Eligibility:
All Genders
Phase:
NA
Brief Summary
The increasing shift from face-to-face to online patient-clinician encounters in the healthcare system requires patients to be more involved in their medical care. This raises the urgent need to evalu...
Eligibility Criteria
Inclusion
- Gastrointestinal (GI) cancer patients
- Chemotherapy session within a specific round of treatment, with eligible treatments including FOLFOX, FOLFIRINOX, and FLOT.
- Hebrew speakers.
Exclusion
- Impaired or degraded cognitive capabilities that may hinder effective learning.
- Individuals who discontinue their treatments due to terminal advancement of their disease or death.
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06187610
Start Date
October 1 2022
End Date
November 1 2024
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ichilov Hospital
Tel Aviv, Israel, 6423906